Alexander Merleev

6PUBLICATIONS
29CO-AUTHORS
Haematological tumoursPredictive and prognostic markersMedical infection agents (incl. prions)Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Feb 24, 2026
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Nov 10, 2025
A phase 1 study of blinatumomab/lenalidomide in relapsed/refractory B-cell lymphoma: toxicity, efficacy, and correlative analysis.

Joseph M Tuscano, Tamer Othman, Paul Frankel

|Jul 12, 2024
Melanoma progression and prognostic models drawn from single-cell, spatial maps of benign and malignant tumors.

Nick R Love, Claire Williams, Emily E Killingbeck

|Mar 22, 2023
KSHV uses viral IL6 to expand infected immunosuppressive macrophages.

Michiko Shimoda, Tomoki Inagaki, Ryan R Davis

|Jun 05, 2021
Long-term Follow-up and Correlative Analysis of Two Phase II Trials of Rituximab and Lenalidomide Followed by Continuous Lenalidomide in Untreated and Relapsed/Refractory Indolent Lymphoma.

Joseph M Tuscano, Christina Poh, Paul Kaesberg

|Jun 26, 2019
IL-1β Induces the Rapid Secretion of the Antimicrobial Protein IL-26 from Th17 Cells.

David I Weiss, Feiyang Ma, Alexander A Merleev

Pageof 1

Frequent Collaborators

3 joint publications

Emanual Maverakis

3 joint publications

Guilluame Luxardi

2 joint publications

Elad Sharon

2 joint publications

Francine M Foss